ArticleOrthopaedic surgery2026
Core Decompression Combined With Superselective Intra-Arterial Perfusion for Osteonecrosis of the Femoral Head: Prognostic Factor-Driven Analysis of Efficacy.
Article in Orthopaedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hip Arthroscopy With Triangular Drilling and Suction Decompression for Osteonecrosis of the Femoral Head: A Retrospective Study.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
- Core Decompression Combined With Superselective Intra-Arterial Perfusion for Osteonecrosis of the Femoral Head: Prognostic Factor-Driven Analysis of Efficacy.Orthopaedic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundOsteonecrosis of the femoral head (ONFH) is a progressive and disabling disease that commonly affects young and middle-aged adults. Without timely treatment, it often progresses to femoral head collapse and hip dysfunction, ultimately requiring total hip arthroplasty. Although core decompression (CD) and superselective intra-arterial perfusion have been applied clinically, their long-term efficacy as monotherapy remains limited, and the clinical value of combining these approaches has not been fully clarified.
objectivesThis study aimed to evaluate the clinical efficacy of CD combined with superselective intra-arterial perfusion in the treatment of ONFH, and to identify key prognostic factors influencing therapeutic outcomes.
methodsThis study enrolled 145 patients in the CD group, 123 in the SIAE group, and 89 in the combined group. Preoperative baseline characteristics, postoperative Harris Hip Scores (HHS), Visual Analog Scale (VAS) scores, MRI-derived collapse rates, and complication rates were compared. Patients were stratified into effective and non-effective groups to analyze risk factors. Receiver operating characteristic (ROC) curves assessed predictive performance.
resultsBaseline characteristics, including sex, age, body mass index (BMI), Association Research Circulation Osseous (ARCO) staging, etiology, and lesion location, showed no intergroup differences. The combined group exhibited superior postoperative HHS improvement, VAS reduction, and collapse rate mitigation compared to monotherapy groups. Complication rates were lowest in the combined group (2.2%) versus CD (7.6%) and SIAE (12.2%) groups. The combined group had the highest efficacy rate, with non-traumatic etiology and marginal necrosis predominating in the effective group. Logistic regression identified surgical approach, BMI, etiology, and lesion location as independent predictors of efficacy. Surgical approach demonstrated the highest predictive power (area under the curve (AUC) = 0.7838, sensitivity 83.75%, specificity 60.41%), while the constant term achieved optimal performance (AUC = 0.8549).
conclusionCD combined with SIAE significantly enhances clinical outcomes, alleviates pain, reduces collapse rates, and minimizes complications in ONFH. Surgical approach, BMI, etiology, and lesion location critically influence efficacy. The combined strategy represents a superior intervention with promising clinical applicability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.